TNF and inflammatory bowel disease: The greatest differences in the frequencies of VH mutations were observed in the cMBCs, with the cMBCs of patients with IBD treated with anti-TNF exhibiting lower mutation frequencies compared with the other 2 groups after dose 2 (Figure 6B).